申请人:Allergan Sales, Inc.
公开号:US06048873A1
公开(公告)日:2000-04-11
Compounds of Formula 1 ##STR1## where Y is a bivalent radical having Formula 2 or Formula 3 where o is an integer from 1 to 4 ##STR2## where the remaining symbols have the meaning described in the specification are selective agonists of RXR retinoid receptors.
式1的化合物##STR1##中,Y是具有式2或式3的二价基团,其中o是从1到4的整数##STR2##,其中其余符号具有规范中描述的含义,是RXR视黄醇受体的选择性激动剂。